PubMed Health⌕ Search

Biomedical subjects

M Tröger

Publications and source records attributed to M Tröger.

13 recordsLinked to original sources
PubMed2004

Normal brain activation in hemiatrophy due to multiple sclerosis: a functional MRI case study.

Evidence from recent functional magnetic resonance imaging studies suggests that adaptive cortical changes ('plasticity') could participate in the maintenance of function in multiple sclerosis (MS). Here, we addressed the impact of brain atrophy on the pattern of cerebral activation in an MS patient with a relapsing-remitting course. This patient showed mildly disabling hemiparesis of the left side (EDSS 2.0), and corresponding brain hemiatrophy (15% volume reduction) of the right hemisphere. The clinical syndrome was considered to result from a lesion in the corona radiata involving corticospinal fibers. Motor-evoked potential recordings confirmed substantial axonal damage to the pyramidal tract arising from that hemisphere. Irrespective of these asymmetries, normal brain activation was found for hand and foot movements for both brain sides. This demonstrates that brain atrophy itself does not necessarily induce cortical adaptive changes, even if mild disability is present. On the other hand, significantly disabling distinct clinical syndromes e.g. arising from spinal cord lesions may evoke cortical changes irrespective of brain atrophy. This issue has to be studied in longitudinal investigations.

Adult↗
PubMed2001

[Effectiveness of botulinum toxin A in the treatment of gustatory sweating].

Frey's syndrome is present in almost all patients after parotidectomy. Gustatory sweating reduces quality of life. Injections of botulinum toxin A have recently been described as effective. This study was designed to evaluate the efficacy of this new treatment. Nineteen patients with severe gustatory sweating following superficial parotidectomy were treated. One unit/cm2 botulinum toxin A was injected intracutaneously into the affected area once. Minor's starch iodine test was performed to prove the outcome of therapy 4 weeks later. Eight patients lost their sweating. However, another seven patients had some blue spots on their cheeks. In four patients whose sweating had extended beyond the hairline, remnants of gustatory sweating showed up. Overall, the affected area of gustatory sweating could be reduced by botulinum toxin A from an average of 31 cm2 before treatment to 4 cm2 after treatment. Although there were some remnants of sweating in a few patients, Frey's syndrome was gone in all cases. No side effects could be observed. Intracutaneous injections of botulinum toxin A are highly effective and safe in treatment of gustatory sweating.

Adult↗
PubMed2001

[Frey syndrome after lateral parotidectomy. Follow-up and therapeutic outlook].

BACKGROUND: Gustatory sweating is a common complication of parotid surgery. PATIENTS AND METHODS: In order to evaluate the incidence of Frey's syndrome following superficial parotidectomy, 69 patients who underwent surgery due to adenoma were studied. Forty-three patients (62%) suffered from gustatory sweating following superficial parotidectomy, and 33 of them requested treatment. Nineteen patients felt that their quality of life had been decreased by the symptoms. RESULTS: Minor's starch iodine test proved that 85% of the patients who did not notice Frey's syndrome after surgery actually had a subclinical manifestation. Eight patients were successfully treated with intracutaneous injections of botulinum toxin A. Within 1 week gustatory sweating disappeared. CONCLUSION: Frey's syndrome is present in almost all patients following superficial parotidectomy and there is a strong need for treatment. Intracutaneous injection of botulinum toxin A is an effective treatment in severe cases of the syndrome.

Adenoma↗
PubMed2000

Botulinum toxin treatment of cocontractions after birth-related brachial plexus lesions.

The authors studied botulinum toxin type A therapy of severe biceps-triceps cocontractions after nerve regeneration following birth-related brachial plexus lesions. Six children (age, 2 to 4 years) were treated two to three times over a period of 8 to 12 months with 40 mouse units of botulinum toxin at two sites of the triceps muscle. Elbow range of motion improved from 0 to 25 to 50 deg to 0 to 25 to 100 deg (p < 0.05), and muscle force of elbow flexion increased from a mean of Medical Research Council classification 1.7 to 3.7 (p < 0.05). After a 1-year follow-up, there was no clinical recurrence.

Birth Injuries↗
PubMed2000

The role of electromyography (EMG) in the diagnosis of ALS.

Electromyography (EMG) plays a key role in the diagnostic evaluation of ALS. This paper deals with the contribution of conventional needle EMG and electroneurography to the neurophysiological assessment of ALS. In addition, special EMG techniques such as single fibre EMG and macro EMG are discussed as they mirror the decline of the number of motor units during the disease process and the remodelling capacity of the surviving motor units.

Amyotrophic Lateral Sclerosis↗
PubMed2000

Revascularized muscle transfer for facial reanimation after long-standing facial paralysis.

The aim of the present study was to evaluate the results of a group of patients who had received free vascularized muscle transfer to the face for the treatment of long-standing facial paralysis. In 15 patients, neurovascular transfer of 16 segments of the gracilis muscle to the cheek was performed for reanimation of oral commissure movement. Voluntary muscle activation was evaluated by electromyography (EMG) and clinical function was assessed both metrically from frontal photographs and by a rating system with 6 categories. Patient satisfaction was explored through a self-administered questionnaire of general health (SF-36 health survey). The average follow-up period was 49.3 months. All patients showed voluntary activation of the grafted muscles in the EMG. Symmetry of the static and dynamic position of the oral commissure at rest and under function was considerably improved. In general, however, there was a tendency for undercorrection particularly in a vertical direction. Under function, the excursion of the oral commissure on the grafted side reached 63.7% and 65.5% of the nonparetic side in vertical and horizontal directions, respectively. Subjective rating of patient well-being showed that the scores were higher than or comparable to those of healthy adults in six of eight areas of evaluation.

Adolescent↗
PubMed1999

A syndrome of psychosis following discontinuation of an estrogen-progestogen contraceptive and improvement following replacement: A case report.

Mild forms of psychosis associated with low estrogen levels during the perimenopause are relatively frequent. There is scarce data on severe forms of psychosis in these conditions. We report the case of a 51-year-old woman with no previous psychiatric history who amputated her hand in a 'psychotiform' state after discontinuation of her contraceptive medication. Having subsequently jumped out of a window, she suffered a fracture of the dens with central spinal cord injury and symptoms of cruciate paralysis. The patient stabilized under a combined therapy with estrogen-progestogen substitution, antipsychotic medication and add-on oxcarbazepine.

Adult↗
PubMed1998

Recognition memory deficits in amyotrophic lateral sclerosis assessed with event-related brain potentials.

OBJECTIVES: Amyotrophic lateral sclerosis (ALS) has been shown to cause neuropsychological deficits. The present investigation sought to delineate memory deficits by recording cognitive event-related potentials (ERPs). SUBJECTS AND METHODS: Eight ALS patients and 8 matched controls were subjected to a 2-phase recognition memory test. During the first phase words were presented consecutively on a video-screen with one-third of the words being repeated. The subject had to press buttons according to whether a word had been repeated or not. During the second phase (delay 1 h) a second list containing 33% old items from phase 1 and 66% new words was shown with an old/new decision required. RESULTS: ALS patients showed less accurate recognition in the second phase. The ERPs of the controls showed a reliable difference between old and new items in both phases. This difference was nearly absent in the patients in both phases. CONCLUSION: The ERP pattern suggests abnormal memory processes in ALS. The results are compared with data from similar experiments in Huntington's and Alzheimer's disease and are interpreted in terms of an encoding deficit in ALS.

Adult↗
PubMed1997

Impact of riluzole on the relationship between patient and physician.

To date, there has been little systematic research on the patient-physician relationship in amyotrophic lateral sclerosis (ALS). Important factors in this relationship are the emotional state, or mood, of the patients and their expectations of successful therapeutic intervention. In many patients there is a gradual deterioration of mood with disease progression-a view supported by studies comparing the initial and late phases of the disease. The few studies examining patients' expectations of therapy revealed a strong desire to be informed about the disease and its course without destroying every hope. In the later stages of the disease patients expected compassion and help with immediate problems. To our knowledge there has been no systematic study on the attitude of physicians towards ALS patients. The lack of effective treatment and the wish to avoid full information about the poor prognosis are almost unique problems involved in dealing with ALS patients. The new option to treat with a drug that slows disease progression provides some alleviation for the physician. Riluzole, at least, partially meets this expectation. Although its efficacy is too limited to satisfy fully the wishes of patients and physicians, it is the first available drug that has been shown to slow disease progression. Thus, it may bring to an end the feeling that there is nothing that can be done for these patients. In our experience this provides relevant alleviation in the management of ALS patients.

Amyotrophic Lateral Sclerosis↗